The Postmenopausal Vaginal Atrophy (VVA) treatment Industry is witnessing a transformative era, driven by an aging global population and a significant shift in how women’s health is addressed. Often referred to under the broader umbrella of Genitourinary Syndrome of Menopause (GSM), vaginal atrophy affects approximately 50% of postmenopausal women, leading to symptoms like dryness, it... https://www.databridgemarketresearch.com/reports/global-postmenopausal-vaginal-atrophy-treatment-market